Established in 2020 Wednesday, March 27, 2024


An acoustically actuated microscopic device
Researchers at EPFL have developed remote-controlled, mechanical microdevices that, when inserted into human tissue, can manipulate the fluid that surrounds them, collect cells or release drugs. This breakthrough offers numerous potential applications in the biomedical field, from diagnostics to therapy. Image courtesy: © 2020 EPFL.



LAUSANNE.- Does the idea of a soft, cell-sized capsule that can be injected into your body in order to collect samples for biopsy, release medication or carry out targeted interventions seem unimaginable? It wasn’t for the scientists in EPFL’s MicroBioRobotic Systems Laboratory (MICROBS), who have come up with technology that does all of these things. “The core component of our device is an acoustic microengine, which we manufactured using 3D nanoprinting,” says Selman Sakar, a professor at the Institute of Mechanical Engineering. “The parts are made out of hydrogel, a biocompatible material that is about as stiff as human tissue. We then drew on computational simulations to invent a complex microdevice consisting of several engines.”

Remote actuation
“After the device enters the body, it has to be actuated remotely,” says Sakar. “It would be too invasive to use tethers such as cables or tubes.” The researchers use ultrasound to actuate the specific microengines and manipulate the surrounding fluid. “The device works precisely because of its structural design. Using mechanical resonance, we can carefully control which part of the device is actuated by modulating the frequency of acoustic excitation.”

Sakar’s team has also developed an array of engines and mechanisms. By combining various parts – pumps, a collection chamber and filters of various sizes – they designed a biopsy device. The researchers have also built mobile devices that are propelled by the fluid flow generated by acoustic microengines.




Programmable in vivo pharmacology and targeted therapy
Combining this technology with medical imaging means patients will be able to undergo long-term monitoring without any outside intervention. “We have freed microfluidics technology from its electronic and external constraints,” says Murat Kaynak, lead author of the study. “Microfluidic devices can now be injected into human tissue and used to greatly enhance biochemical analysis thanks to the tunability of hydrogels.”

The devices could also be used for therapeutic purposes. “Doctors will be able to program the device to release a specific drug dosage when actuated by ultrasound,” adds Kaynak. “This will allow them to treat a specific part of the body and minimize the side effects.”

Controlled lifespan
While injecting the microscopic devices is minimally invasive, removing the devices has proven more of a challenge. The solution can be found in the materials used to construct the device. “How long a device lasts depends on the materials it’s made of,” says Kaynak. “Some hydrogels biodegrade quickly while others stick around longer. The actuation concept works well with various types of polymers.”

Only in vitro experiments have been conducted so far. The next step will be to test these devices in vivo.







Today's News

September 22, 2020

An acoustically actuated microscopic device

AI could expand healing with bioscaffolds

NASA publishes Artemis plan to land first woman, next man on Moon in 2024

Trump touts swift vaccine as Europe battles virus second wave

Children's immune response more effective against COVID-19

'Best' hospitals should be required to deliver tobacco treatment

A link between sensory neurons activation and the immune system

Helping robots avoid collisions

Over 60 wealthy nations join WHO's Covid-19 vaccine plan

Airbus aims for hydrogen-powered plane by 2035

Health messages to help stop patient harm in hospitals

Arctic ice melt doesn't boost sea levels, so do we care?

Astronomers discover an Earth-sized "pi planet" with a 3.14-day orbit

Evaluating battery revenues for offshore wind farms using advanced modeling

SMART researchers develop fast and efficient method to produce red blood cells

Tulane chemistry professor receives national award

Jellyfish with your chips?

Landmark deal for UQ-Trinity inflammation startup



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful